DermTech, Inc(NASDAQ:DMTK) 
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and t...
Website: http://www.dermtech.com
Founded: 1996
CEO / Founder: John Dobak, M.D.
Sector: Healthcare
Industry: Diagnostics & Research
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-01-29
P
O 1.31
H 1.36
L 1.28
C 1.33
V 194,488
10EMA 1.33
20EMA 1.33
60EMA 1.33
120EMA 1.33
250EMA 1.33